Title : 4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B - Mazej_2021_Molecules_26_ |
Author(s) : Mazej T , Knez D , Meden A , Gobec S , Sova M |
Ref : Molecules , 26 : , 2021 |
Abstract : |
PubMedSearch : Mazej_2021_Molecules_26_ |
PubMedID: 34299393 |
Title : Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities - Knez_2018_Eur.J.Med.Chem_156_598 |
Author(s) : Knez D , Coquelle N , Pislar A , Zakelj S , Jukic M , Sova M , Mravljak J , Nachon F , Brazzolotto X , Kos J , Colletier JP , Gobec S |
Ref : Eur Journal of Medicinal Chemistry , 156 :598 , 2018 |
Abstract : |
PubMedSearch : Knez_2018_Eur.J.Med.Chem_156_598 |
PubMedID: 30031971 |
Gene_locus related to this paper: human-BCHE |
Title : Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease - Knez_2017_Future.Med.Chem_9_811 |
Author(s) : Knez D , Sova M , Kosak U , Gobec S |
Ref : Future Med Chem , 9 :811 , 2017 |
Abstract : |
PubMedSearch : Knez_2017_Future.Med.Chem_9_811 |
PubMedID: 28504893 |